Cargando…

Preliminary evaluation of deep learning for first-line diagnostic prediction of tumor mutational status

The detection of tumour gene mutations by DNA or RNA sequencing is crucial for the prescription of effective targeted therapies. Recent developments showed promising results for tumoral mutational status prediction using new deep learning based methods on histopathological images. However, it is sti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morel, Louis-Oscar, Derangère, Valentin, Arnould, Laurent, Ladoire, Sylvain, Vinçon, Nathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147624/ https://www.ncbi.nlm.nih.gov/pubmed/37117277 http://dx.doi.org/10.1038/s41598-023-34016-y

Ejemplares similares

PIK3CA and PIK3R1 tumor mutational landscape in a pan-cancer patient cohort and its association with pathway activation and treatment efficacy
por: Tharin, Zoé, et al.
Publicado: (2023)

Evaluation of tumor immune contexture among intrinsic molecular subtypes helps to predict outcome in early breast cancer
por: Klopfenstein, Quentin, et al.
Publicado: (2021)

RAS status and neoadjuvant chemotherapy impact CD8+ cells and tumor HLA class I expression in liver metastatic colorectal cancer
por: Ledys, Fanny, et al.
Publicado: (2018)

Liver X Receptor ligand cytotoxicity in colon cancer cells and not in normal colon epithelial cells depends on LXRβ subcellular localization
por: Courtaut, Flavie, et al.
Publicado: (2015)

Molecular intrinsic subtypes, genomic, and immune landscapes of BRCA-proficient but HRD-high ER-positive/HER2-negative early breast cancers
por: Ballot, Elise, et al.
Publicado: (2022)

Efficacy of platinum-based chemotherapy in metastatic breast cancer and HRD biomarkers: utility of exome sequencing
por: Galland, Loïck, et al.
Publicado: (2022)

Association of Anti-EGFR Antibody and MEK Inhibitor in Gynecological Cancer Harboring RAS Mutation: A Case Series
por: Niogret, Julie, et al.
Publicado: (2022)

Anticipating changes in the HER2 status of breast tumours with disease progression—towards better treatment decisions in the new era of HER2-low breast cancers
por: Bergeron, Anthony, et al.
Publicado: (2023)

Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer?
por: Derangère, Valentin, et al.
Publicado: (2016)

Tracking the evolution of circulating exosomal-PD-L1 to monitor melanoma patients
por: Cordonnier, Marine, et al.
Publicado: (2020)

Bleomycin Exerts Ambivalent Antitumor Immune Effect by Triggering Both Immunogenic Cell Death and Proliferation of Regulatory T Cells
por: Bugaut, Hélène, et al.
Publicado: (2013)

IRF8-dependent molecular complexes control the Th9 transcriptional program
por: Humblin, Etienne, et al.
Publicado: (2017)

Performance of [18F]FDG-PET/CT Imaging in First Recurrence of Invasive Lobular Carcinoma
por: Bonnin, David, et al.
Publicado: (2023)

First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial
por: Thibaudin, Marion, et al.
Publicado: (2023)

Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy
por: Fumet, Jean-David, et al.
Publicado: (2018)

Correction: Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy
por: Fumet, Jean-David, et al.
Publicado: (2019)

TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer
por: Lecuelle, Julie, et al.
Publicado: (2021)

First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?
por: Vano, Yann-Alexandre, et al.
Publicado: (2021)

Induction of pyroptosis in colon cancer cells by LXRβ
por: Rébé, Cédric, et al.
Publicado: (2015)

Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer
por: Galland, Loïck, et al.
Publicado: (2023)

A preliminary examination of the diagnostic value of deep learning in hip osteoarthritis
por: Xue, Yanping, et al.
Publicado: (2017)

Un service de soins urgents externes de kinésithérapie respiratoire pédiatrique à l'hôpital
por: Vinçon, C
Publicado: (1995)

Ultrasound as First Line Step in Anaemia Diagnostics
por: Mozzini, Chiara, et al.
Publicado: (2019)

Prognosis of local invasive relapses after carcinoma in situ of the breast: a retrospective study from a population-based registry
por: Kada Mohammed, Samia, et al.
Publicado: (2022)

Evolution of RAS Mutational Status in Liquid Biopsies During First-Line Chemotherapy for Metastatic Colorectal Cancer
por: Klein-Scory, Susanne, et al.
Publicado: (2020)

Transcriptional expression of 8 genes predicts pathological response to first-line docetaxel + trastuzumab-based neoadjuvant chemotherapy
por: Schmitt, Esther, et al.
Publicado: (2015)

Diagnostics as the first line of defense in global health security
por: Kessel, Mark
Publicado: (2014)

Using a convolutional neural network for classification of squamous and non-squamous non-small cell lung cancer based on diagnostic histopathology HES images
por: Le Page, Anne Laure, et al.
Publicado: (2021)

Custom multi-tumor next-generation sequencing panel for routine molecular diagnosis of solid tumors: Validation and results from three-year clinical use
por: Chevrier, Sandy, et al.
Publicado: (2022)

T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survival
por: Ladoire, S, et al.
Publicado: (2011)

Optimization of routine KRAS mutation PCR-based testing procedure for rational individualized first-line-targeted therapy selection in metastatic colorectal cancer
por: Chretien, Anne-Sophie, et al.
Publicado: (2013)

Memorandum: status of NA9-data analysis and first preliminary uncorrected results
por: Brasse, F W
Publicado: (1981)

An Alternative Diagnostic Method for C. neoformans: Preliminary Results of Deep-Learning Based Detection Model
por: Seyer Cagatan, Ayse, et al.
Publicado: (2022)

Atezolizumab and paclitaxel as first line therapy in advanced triple-negative breast cancer patients included in the French early access program
por: de Moura, Alexandre, et al.
Publicado: (2023)

The first aphasia screening test in Hungarian: A preliminary study on validity and diagnostic accuracy
por: Zakariás, Lilla, et al.
Publicado: (2023)

Intranasal midazolam as first‐line inhospital treatment for status epilepticus: a pharmaco‐EEG cohort study
por: Kay, Lara, et al.
Publicado: (2019)

Preliminary exploration of the effects of environmental factors on the microsatellite status of BRAF-mutated colorectal cancer
por: Tian, Binle, et al.
Publicado: (2023)

Tumor Infiltrating Lymphocytes Signature as a New Pan-Cancer Predictive Biomarker of Anti PD-1/PD-L1 Efficacy
por: Ballot, Elise, et al.
Publicado: (2020)

Therapeutic Associations Comprising Anti-PD-1/PD-L1 in Breast Cancer: Clinical Challenges and Perspectives
por: Ledys, Fanny, et al.
Publicado: (2021)

Rituximab as a first-line preventive treatment in pediatric NMOSDs: Preliminary results in 5 children
por: Longoni, Giulia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8h8uhirbe9acq72h47lg8hncki